Allogene Therapeutics (ALLO) Interest Coverage Ratio (2018 - 2026)

Allogene Therapeutics has disclosed Interest Coverage Ratio across 4 years of filings, most recently posting 153.64 for Q1 2026.

• Interest Coverage Ratio for Q1 2026 came in at 153.64, up 64.65% year-over-year; the trailing twelve-month figure through Mar 2026 was 155.28 (up 80.89% YoY), and the FY2025 annual result was 194.71, up 87.1% from the prior year.
• Interest Coverage Ratio came in at 153.64 for Q1 2026 at Allogene Therapeutics, down from 135.48 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 130.53 in Q3 2025 to a low of 746.79 in Q4 2024.
• The 3-year median for Interest Coverage Ratio is 212.01 (2025), against an average of 361.54.
• Across the five-year window, Interest Coverage Ratio jumped 81.86% in 2025 and surged 64.65% in 2026, its largest moves.
• Allogene Therapeutics' Interest Coverage Ratio stood at 746.79 in 2024, then surged by 81.86% to 135.48 in 2025, then retreated by 13.41% to 153.64 in 2026.
• The last three Interest Coverage Ratio figures came in at 153.64 (Q1 2026), 135.48 (Q4 2025), and 130.53 (Q3 2025), per Business Quant data.